tiprankstipranks
ArriVent BioPharma, Inc. (AVBP)
NASDAQ:AVBP
US Market

ArriVent BioPharma, Inc. (AVBP) Income Statement

Compare
26 Followers

ArriVent BioPharma, Inc. Income Statement

Last quarter (Q4 2024), ArriVent BioPharma, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, ArriVent BioPharma, Inc.'s net income was $-20.63M. See ArriVent BioPharma, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 74.59M$ 36.91M$ 8.70M
Depreciation and Amortization
$ 0.00$ 36.91M$ 11.59M
EBITDA
$ -74.59M$ -36.91M$ -51.61M
Operating Income
$ -74.59M$ -36.91M$ -8.70M
Other Income/Expenses
$ 5.26M$ 0.00$ -60.11M
Pretax Income
$ -69.33M$ -36.91M$ -51.61M
Net Income
$ -69.33M$ -36.91M$ -51.61M
Per Share Metrics
$ ―$ ―$ ―
Basic EPS
$ -2.17$ -1.10$ -1.54
Diluted EPS
$ -2.17$ -1.10$ -1.54
Weighted Average Shares Outstanding
31.96M 33.49M 33.49M
Weighted Average Shares Outstanding (Diluted)
31.96M 33.49M 33.49M
Currency in USD

ArriVent BioPharma, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis